Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Eliprodil
SL 82-0715

Action
Glutamate antagonist (NMDA polyamine site blocker)

Status
Phase III stroke trials abandoned 1997.

Trial(s)
  = Ongoing
  = Completed

Eliprodil Phase 3 Eliprodil Trial

Web Links and Publications
Sanofi-Synthelabo Web Site.
Cerestat and other NMDA antagonists in ischemic stroke.
Neurology 1997 Nov;49(5) Suppl 4):S66-S69.

UID: 17

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2010 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, March 12, 2010